glp-1 and glp-2 drugs are all approved for glucose control in type 2 diabetes (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, obesity. None GLP-1 Drugs and the Physiology
Description
Click here to listen to this article Share via See more from the L.A
G., Pozzi, A., Zent, R
The biorepository targets the collection of milk samples and self-related health information for mother and infant dyad via a questionnaire
The key point: the ingredient is not the same as the finished drug
linagliptin needs no renal adjustment Limitations & safety Cardiovascular outcome trials (CVOTs) PBS rules (Authority Required Streamlined) Must be used with metformin sulfonylurea and/or insulin
